Abstract:Objective To explore the time window of bevacizumab to normalize the vascular for tumor and analyze the efficacy of bevacizumab plus paclitaxel in lung cancer-bearing mice.Methods Athymic mice bearing A549 xenografts were constructed.The study can be divided into two parts.In first part, 24 nude mice were randomly assigned into two groups (n=12 per group): control group (intraperitoneal injection of saline) and bevacizumab group (intraperitoneal injection of bevacizumab 5 mg/kg).At four time points after injection (1, 3, 5, 8 d;n=3 at each time point), the volume of tumor and the weight of nude mice were measured.Meanwhile, the levels of vascular endothelial growth factor (VEGF) and microvessel density (MVD) in tumor tissues were detected by Western blotting and immunofluorescence methods, respectively.In second part, 30 nude mice were randomly divided into four groups: control group (n=5), bevacizumab monotherapy group (n=5), paclitaxel monotherapy group (n=5) and paclitaxel plus bevacizumab group (n=15).On the day of administration or the third and fifth day after administration of bevacizumab, paclitaxel plus bevacizumab group received intraperitoneal injection of paclitaxel with five mice at each time point.The paclitaxel and bevacizumab were administered at doses of 3 mg/kg and 5 mg/kg, respectively.The volumes of tumor were measured at 6 time points including 3, 7, 10, 14, 17, 20 days after administration.The nude mice were killed and the weight of tumor was measured 21 days later.The VEGF and MVD of the tumor were detected by Western blotting and immunohistochemistry.Results In the first part of our study, the tumor growth was suppressed gradually after the treatment of bevacizumab as compared with control group.Tumor volume, VEGF level and MVD reached a nadir at 3 days after bevacizumab administration.In the second part, compared with the control group, bevacizumab in combination with paclitaxel at different time points could suppress the tumor growth with a much significant inhibition effect on day 3 after bevacizumab administration.The average tumor volume, tumor weight, VEGF level and MVD were less in combined administration on day 3 than other combined groups.Conclusion The possible timing of the normalization window was typically 1-3 days after the administration of bevacizumab.The normalization window may provide an opportunity to enhance the effect of paclitaxel with the aid of bevacizumab.

Inhibition of Growth and Metastasis of Tumor in Nude Mice after Intraperitoneal Injection of Bevacizumab.

Effect of bevacizumab in the RFP-tagged osteosarcoma nude mice model of human osteosarcoma in vivo

Effect of bevacizumab on angiogenesis and related cytokines in mice with malignant pleural effusion

Bevacizumab for the Treatment of Gammaknife Radiosurgery-Induced Brain Radiation Necrosis

An Experimental Research into Endostatin Microbubble Combined with Focused Ultrasound for Anti-Tumor Angiogenesis in Colon Cancer

Effect of bevacizumab combined with chemotherapy at different sequences in the gastric-cancer-bearing nude mice

Impacts of Bevacizumab on vascular endothelial growth factor and Sp1 expression in gastric cancer xenografts

[Morphological Changes in Osteosarcoma Xenografts in Nude Mice after Inhibiting Angiogenesis by Ad-VEGF-siRNA].

Impact of Anti-Angiogenic Treatment on Bone Vascularization in a Murine Model of Breast Cancer Bone Metastasis Using Synchrotron Radiation Micro-CT

Experimental study of vascular normalization window for tumor induced by bevacizumab and efficacy of bevacizumab plus paclitaxel in lung cancer-bearing mice

[Effect of Anti-Vascular Endothelial Growth Factor Antibody on the Progression of Human Gastric Cancer Orthotopic Xenotransplanted into Nude Mice].

[The Influence of Ad-AVEGF165 on Human Malignant Melanoma Growth in Nude Mice].

Study on the Anti-Angiogenic Activity of Tumstatin Related Peptide T3 Mediated by Short Peptide to Osteosarcoma Vascular

Effects of adenovirus-mediated VEGF-siRNA on the growth of xenografted human osteosarcoma in nude mice

[Therapeutic Effects of Avastin on the Murine Hemangioendothelioma].

Reducing Intratumour Acute Hypoxia Through Bevacizumab Treatment, Referring to the Response of Quiescent Tumour Cells and Metastatic Potential.

Inhibition of Growth and Metastases of Inoculated Human Prostate Cancer in Nude Mice by Antisense Vascular Endothelial rowth Factor

The Effect of Antibody Against Vascular Endothelial Growth Factor on Tumor Growth and Metastasis.

Effect of angiostatin gene on growth and metastasis of pancreatic carcinoma strain PC-3 orthotopic implantation model in mice

[The Effect of Antibody Against Vascular Endothelial Growth Factor (VEGF) on Tumor Metastasis].

Experimental Study on Early Effects of Bevacizumab Evaluated by Dynamic Enhanced Magnetic Resonance Imaging